2b
A decade ago, Allison Ellsworth was drinking apple cider vinegar for health reasons and doctoring it with fruit so she could stand the taste. Her husband Stephe…
In the late 2000s, two French mountain athletes set out to build a running shoe that captured the feeling of flying. Jean-Luc Diard and Nicolas “Nico” Mermoud h…
한올바이오파마가 개발해 기술이전한 자가면역질환 치료제 후보물질 ‘아이메로프루바트’가 류마티스관절염 임상 2b상에 성공했다. 같은 작용 기전의 1세대 후보물질 ‘바토클리맙’이 지난 4월 갑상선안병증 임상 3상에서 실패한 뒤 거둔 쾌거다. 다만 넘어야 할 산은 아직 많다. 임상 3상 1건으…
ハンオールバイオファーマが開発し技術移転した自己免疫疾患治療薬候補物質「イメロプルバート」が、関節リウマチの臨床第2b相試験で成功した。同じ作用機序を持つ第1世代候補物質「バトクリマブ」が今年4月、甲状腺眼症の臨床第3相試験で失敗した後に得た快挙だ。ただし、越えるべき山はまだ多い。臨床第3相試験1件で承認を申請できるか…
This is the second snippet of the SOA 2 double-episode. Eberhard and Markus continue the discussion with the issue of service reuse and a couple of development …
Bill Macaitis knows a little bit about growth. In his time as Zendesk CMO, he helped take the company from venture-funded startup through an IPO resulting in a …
